Malcolm S Taub - Net Worth and Insider Trading
Malcolm S Taub Net Worth
The estimated net worth of Malcolm S Taub is at least $694 dollars as of 2024-11-10. Malcolm S Taub is the Director of Brainstorm Cell Therapeutics Inc and owns about 578 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $694. Details can be seen in Malcolm S Taub's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Malcolm S Taub has not made any transactions after 2015-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Malcolm S Taub
Malcolm S Taub Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Malcolm S Taub owns 2 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , and Safer Shot Inc (SAFS) .
Click here to see the complete history of Malcolm S Taub’s form 4 insider trades.
Insider Ownership Summary of Malcolm S Taub
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-12 | director |
| SAFS | Safer Shot Inc | 2007-10-18 | director |
Malcolm S Taub Latest Holdings Summary
Malcolm S Taub currently owns a total of 1 stock. Malcolm S Taub owns 578 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 15, 2015, with a value of $694.
Latest Holdings of Malcolm S Taub
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2015-12-15 | 578 | 1.20 | 694 |
Holding Weightings of Malcolm S Taub
Malcolm S Taub Form 4 Trading Tracker
According to the SEC Form 4 filings, Malcolm S Taub has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the sale of 2,783 shares on December 15, 2015, which brought Malcolm S Taub around $108,529.
Insider Trading History of Malcolm S Taub
- 1
Malcolm S Taub Trading Performance
Malcolm S Taub Ownership Network
Ownership Network List of Malcolm S Taub
Ownership Network Relation of Malcolm S Taub
Malcolm S Taub Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Malcolm S Taub is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Malcolm S Taub made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Malcolm S Taub Mailing Address
Above is the net worth, insider trading, and ownership report for Malcolm S Taub. You might contact Malcolm S Taub via mailing address: 1350 Avenue Of The Americas, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
